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Abstract. Several processes that occur in the luminal 
compartments of the tissues are modulated by heparin- 
like polysaccharides. To identify proteins responsible 
for the expression of heparan sulfate at the apex of po- 
larized cells, we investigated the polarity of the expres- 
sion of the cell surface heparan sulfate proteoglycans in 
CaCo-2 cells. Domain-specific biotinylation of the api- 
cal and basolateral membranes of these cells identified 
glypican, a GPI-linked heparan sulfate proteoglycan, as 
the major source of apical heparan sulfate. Yet, most of 
this proteoglycan was expressed at the basolateral sur- 
face, an unexpected finding for a glypiated protein. 
Metabolic labeling and chase experiments indicated 
that sorting mechanisms, rather than differential turn- 
over, accounted for this bipolar expression of glypican. 
Chlorate treatment did not affect the polarity of the ex- 
pression of glypican in CaCo-2 cells, and transfectant 
MDCK cells expressed wild-type glypican and a synde- 
can-4/glypican chimera also in an essentially unpolar- 
ized fashion. Yet, complete removal of the heparan sul- 
fate glycanation sites from the glypican core protein 
resulted in the nearly exclusive apical targeting of glyp- 
ican in the transfectants, whereas two- and one-chain 
mutant forms had intermediate distributions. These re- 
suits indicate that glypican accounts for the expression 
of apical heparan sulfate, but that glycanation of the, 
core protein antagonizes the activity of the apical sort- 
ing signal conveyed by the GPI anchor of this pro- 
teoglycan. A possible implication of these findings is 
that heparan sulfate glycanation may be a determinant 
of the subcellular expression of glypican. Alternatively, 
inverse glycanation-apical sorting relationships in glyp- 
ican may insure near constant deliveries of HS to the 
apical compartment, or "active" GPI-mediated entry of 
heparan sulfate into apical membrane compartments 
may require the overriding of this antagonizing effect 
of the heparan sulfate chains. 
T 
HE heparan sulfate proteoglycans (HSPGs)  1 of the 
cell surface bind a variety of ligands. The activities of 
these  ligands  and  the  functional  consequences of 
their interactions with heparin-like polysaccharides impli- 
cate the heparan  sulfate proteoglycans in mechanisms of 
cell adhesion and recruitment, cell differentiation and pro- 
liferation,  and in the control of proteolytic and  lipolytic 
pathways (reviewed by Bernfield et al., 1992; David, 1993). 
Fibroblast growth factors and vascular endothelial growth 
factor, for example, depend on heparan  sulfate (HS) for 
binding to their cognate receptors and for eliciting  a bio- 
logical  response from this  receptor occupancy (Yayon et 
al., 1991; Rapraeger et al., 1991; Gitay-Goren et al., 1992; 
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Spivak-Kroizman et al., 1994). There is also evidence that 
glycosaminoglycan-bound chemokines recruit T cells from 
the circulation (Tanaka et al., 1993), that the binding of 
antithrombin III to endothelial HS accelerates the interac- 
tion of this proteinase inhibitor with proteases of the coag- 
ulation cascade (Bourin and Lindahl, 1993), and that lipo- 
protein  lipase  is  transcytosed  through  endothelia  and 
anchored  to  the  endothelial  membrane  by mechanisms 
that involve binding to cell surface-associated HS (Saxena 
et al., 1991a,b). 
Several distinct proteins have been identified as major 
carriers  of the HS that  is associated with the surface of 
mammalian cells. Four of these, the syndecans, are trans- 
membrane proteins and are grouped as a family because 
of striking  similarities  in domain structure and shared se- 
quence motifs. The membrane-spanning  and cytoplasmic 
domains of the syndecans, in particular,  show significant 
sequence similarity  and have been strongly conserved dur- 
ing evolution (Bernfield et al., 1992). Their mode of asso- 
ciation with the cell surface contrasts with that  of three 
other  proteoglycans,  known  as  glypican  (David  et  al., 
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(Watanabe and Yamaguchi, 1995), that are linked to the 
cell surface via glycosyl phosphatidylinositol (GPI). To- 
gether with  another candidate  member,  the  protein en- 
coded by the OCI-5 transcript (Filmus et al., 1988), these 
proteins  define  a  second  family  of  integral  membrane 
HSPGs, characterized by evolutionarily conserved protein 
cores of similar sizes that share the GPI anchorage mecha- 
nism, a unique cysteine motif that may be involved in the 
stabilization of a compact tertiary structure, and putative 
HS-glycanation sites that occur carboxyl terminally, close 
to the anchor structure that links the protein to the cell 
surface (David, 1993). The precise functions of the various 
syndecan-  and  glypican-like  core  proteins  remain  un- 
known, but  it is  generally assumed  that,  at a  minimum, 
they serve to target functionally critical HS chains to their 
positions on the cell surface and regulate their expressions 
at these sites. 
Studies on the polarized expression of membrane pro- 
teins in epithelial cells have revealed that in many instances 
the transport of proteins to specific membrane compart- 
ments involves defined sorting signals (reviewed by Bom- 
sel and Mostov, 1991). The best-characterized sorting sig- 
nal so far is the GPI anchor, which directs proteins to the 
apical surface of several epithelial cell types. In other cases 
cytoplasmic domains have been shown to be responsible 
for basolateral deliveries, and recent studies, demonstrat- 
ing that cytoplasmic tail deletions affect the transport and 
basolateral targeting of syndecan-1 in transfectant MDCK 
cells (Miettinen et al., 1994), suggest that this may be the 
case for the syndecans. In such a scheme particular pro- 
teoglycan forms might be specialized for particular func- 
tions, not because of the unique binding and catalytic prop- 
erties  of their  HS  chains,  but  because  of their specific 
locations at a functionally relevant place on the cell surface, 
i.e., glypicans in apical and syndecans in basolateral com- 
partments. Previous studies have shown that all syndecans 
and glypican isolated from rat and human vascular endo- 
thelial cells can be substituted with heparan sulfate chains 
that bind to antithrombin III (Kojima et al., 1992; Mertens 
et al., 1992), suggesting that several different core proteins 
isolated from one cell type may carry structurally and func- 
tionally similar HS chains. Yet, HSPGs on the luminal sur- 
face of the endothelium would be the first candidates to 
activate circulating antithrombin III. 
We therefore initiated a study of the subceUular local- 
ization of the different cell surface-associated HSPGs, and 
more specifically of glypican, in CaCo-2 and transfectant 
MDCK cells, polarized cell types that have often been used 
as models for the study of protein trafficking and sorting 
signals. The results of vectorial labeling experiments indi- 
cate that the syndecans expressed by CaCo-2 cells are re- 
stricted  to  the  basolateral  membrane  compartment  of 
these cells. Glypican, in contrast, is expressed in the apical 
membrane and, unexpectedly, also in the basolateral com- 
partment, endogenously in CaCo-2 cells and after trans- 
fection in MDCK cells. Site-directed mutagenesis of the 
glypican cDNA used for the transfection studies and anal- 
ysis of the subcellular expression of glypican forms that 
are substituted with one, two or three HS chains and of 
non  glycanated  forms  indicates  that  substitution  of the 
glypican core protein with HS interferes with the apical sort- 
ing signal that is provided by the GPI anchor of this protein. 
The unexpected differential subcellular expressions of the 
proteoglycan and nonglycanated forms of glypican imply 
that modulated substitution with HS provides a potential 
means of controlling the subcellular expression and func- 
tional availability of this membrane protein. 
Materials and Methods 
Culture and Metabolic Labeling of  the Cells 
Human colon carcinoma cells (CaCo-2) (Zwiebaum, A., 1NSERM ViUejuif, 
France), wild type strain II MDCK (Simons, K., EMBL, Heidelberg, Ger- 
many), and transfectants derived from these MDCK cells were grown in 
DME (GIBCO BRL, Gaithersburg, MD) supplemented with 10%  fetal 
calf serum. For biotinylation experiments, the ceils were plated in 24.5 
mm filter chambers (Costar Corp., Cambridge, MA) provided with col- 
lagen-treated nitrocellulose (Transwell-Col, 0.4  Ixm pore) or tissue cul- 
ture-treated polyester membranes (Transwell-Clear, 0.4 p.m pore), at a 
density of 200,000  cells/well. The medium was renewed every other day 
and experiments were performed 8 d after plating. The apical expression 
of carcino embryonic antigen (CEA) in CaCo-2 cells (see Results) and of 
gp 80 (Mostov et al., 1992) in MDCK cells (not shown) indicated that the 
cells were well polarized at the initiation of the experiment. For the chlor- 
ate-treatment of the cells, the standard DME medium was replaced by a 
low sulfate-DME (0.08 mM SO42-) containing 50 mM chlorate on day two 
after plating, and this medium was renewed every other day. On the 8th 
day, the confluent monolayers were labeled for 24 h with 35SO42- (50 i~Ci/ 
ml; New England Nuclear, Boston, MA) in low sulfate-medium (0.08 mM 
SO42-), with both 358042- (50 ~Ci/m[)  and 3H-glucosamine (20 i~Ci/ml) in 
low sulfate-medium (chlorate-treated ceils), or with [3SS]methionine  and 
[3SS]cysteine (25 i~Ci/ml each; New England Nuclear) in methionine and 
cysteine-free RPMI 1640 medium (ICN Biomedicals, Costa Mesa, CA). 
For the time course label and chase experiments, the CaCo-2 cells were la- 
beled with 3sso42- (200  p.Ci/ml)  in low-sulfate medium for various time 
periods up to 4 h, or labeled for 24 h, and then chased in standard culture 
medium without precursor for various time periods up to 24 h. 
Monoclonal Antibodies 
The mAb used for the immunopurification and detection of the proteogly- 
cans were all raised against proteoglycans of human origin: mAb 3G10 
(anti-A-HS), mAbs S1 and 1Gll (glypican), mAb 2E9 (syndecan-1 and -3), 
mAbs 6G12 and 10H4  (fibroglycardsyndecan-2), mAb 1C-'7 (syndecan-3), 
mAb 8G3 (amphiglycan/syndecan-4), and all have been described before 
(De Boeck et al., 1987; Lodes et al., 1989, 1992; David et al., 1990, 1992). 
The anti-human carcinoembryonic antigen mouse monoclonal antibody 
(DAKO-CEA, A5B7) was obtained from DAKO (Glostrup, Denmark). 
Proteoglycan Extraction and Characterization 
Triton X-100 (TX-100) extraction buffer contained 10 mg/ml TX-100, 150 
mM NaCI, 10 mM Tris/HC1,  pH 8.0, 50 mM 6-aminohexanoic acid, 5 mM 
N-ethylmaleimide, 5 mM benzamidine, 1 mM phenylmethylsulfonyl fluo- 
ride, and 1 Ixg/ml of pepstatin A, pH 7.4. The octylglucoside (OG) extrac- 
tion buffer had the same composition except that TX-100 was replaced by 
60 mM octylglucoside (Boehringer, Mannheim, Germany). Ion-exchange, 
gel-filtration, liposome-incorporation, immunoprecipitation and -blotting 
procedures used to isolate and characterize the proteoglycans from cell 
extracts or media fractions were as described before (Lories et al., 1989; 
Mertens et al., 1992). 
Biotinylation and Detection of 
Biotinylated Proteoglycan 
Filter-grown  monolayers  were  assayed  for  impermeability  by  adding 
[3H]inulin  (Amersham, Buckinghamshire, England) to the apical com- 
partment of the filter chamber (Sargiacomo et al., 1989). Metabolic label- 
ing was initiated in monolayers showing a permeability less than 1%, and 
24 h later the cultures were used for vectorial biotinylation experiments, 
as described by Sargiacomo et al. (1989). Filters were placed on ice, rinsed 
three times with cold phosphate-buffered saline containing 1 mM MgCi2 
and 0.1 mM CaCI2 (PBS-CM), and a freshly made solution of sulfo-NHS- 
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apical or basolateral chamber. The cells were incubated for 20 min at 4°C, 
whereupon the biotinylation procedure was repeated once. The reaction 
was quenched by removing the biotin solution and adding serum-free cul- 
ture medium (10 rain), followed by three washes of the cells with PBS- 
CM, and finally by extraction of the cells with TX-100 or OG buffer (2× 
for 20 min). The detergent extracts were cleared by centrifugation (10,000 
g; 10 rain) and analyzed for their total and biotinylated proteoglycan con- 
tents. 
In one procedure all proteoglycans were bulk purified from the deter- 
gent extracts by ion-exchange chromatography on Mono-Q, treated with 
heparitinase and  chondroitinase ABC,  separated on  6-20%  SDS-poly- 
acrylamide gradient gels, and electrotransferred to a  Zeta-probe mem- 
brane. After overnight inactivation in 1% Tween-20, 0.5% casein, 600 mM 
NaC1, 10 mM NazHPO4, pH 7.4, the membrane was incubated with alka- 
line phosphatase-linked avidin (Tropix, Bedford, MA) (1/5,000)  in PBS 
supplemented with 0.5%  casein and  1%  Tween-20. The membrane was 
rinsed, incubated with the chemiluminescent substrate AMPPD (Tropix) 
and biotinylated core protein was detected by exposure to  Hypeffilm- 
ECL (Amersham, Belgium, Gent) as described previously (Mertens et al., 
1992). 
In the other procedure, each  proteoglycan was individually purified 
from the detergent extracts by immunoabsorption on specific antibody. In 
some experiments the proteoglycans were pre-purified by adsorption on 
DEAE-Trisacryl M, washing with 0.1% TX-100, 0.2 M NaC1, 50 mM Tris/ 
HCI, pH 7.4, and elution in 0.1% TX-100,1 M NaC1, 50 mM Tris/HCl, pH 
7.4. Before immunopurification the samples were adjusted to 0.15 M NaCI 
and supplemented with BSA (50  ixg/ml), heparin (10  i~g/ml), and chon- 
droitin sulfate (10  o.g/ml).  Immunopurification of the proteoglycans on 
immobilized monoclonal antibodies was performed as described before 
(Lories et al., 1989). Immunopurified proteoglycan was dissolved in PBS 
supplemented with BSA (50 g.g/ml) and 0.1% TX-100, and mixed with im- 
mobilized streptavidin (Pierce Chemical Co., Rockford, IL). After incuba- 
tion for 3 h  at 4°C, the streptavidin beads were washed three times with 
PBS  containing  BSA  and  0.1%TX-100.  Streptavidin-bound  and  non- 
bound materials were analyzed for their radiolabel-content by liquid scin- 
tillation counting. Alternatively, the streptavidin-bound label was solubi- 
lized by boiling in 20 mM Tris/HC1  buffer, pH 7.4, containing 2% SDS, 
10%  glycerol, and  0.05%  bromophenol blue. These samples were ana- 
lyzed by SDS-PAGE in a 10% homogeneous acrylamide gel, and autora- 
diography. 
Liposome Incorporation and 
PI-Phospholipase C Digestion 
Immunopurified  35SO32-1abeled proteoglycans  were  incorporated  into 
lipid vesicles as described before (Lories et aI., 1987). Liposome-incorpo- 
rated proteoglycans were separated from the nonincorporated proteogly- 
cans on a sucrose gradient (Andres et al.,  1989). Liposome-incorporated 
fractions in 50 mM Tris/HC1,  pH 7.5, were supplemented with 50 mM oc- 
tylglucoside, 10  mM EDTA  and proteinase inhibitors (see above) and 
treated  with  50  mU  of phosphatidyl  inositol-specific phospholipase C 
(Boehringer, Mannheim, Germany) for 3 h  at 37°C. After the digestion, 
treated and control samples were retested for liposome incorporation as 
described above. 
Transfection of Glypican into MDCK Cells 
The 6zlK3 cDNA coding for wild type human glypican (David et al., 1990) 
and derivative mutant cDNAs (see below) were integrated in the Xbal- 
HindlII restriction sites of the pRcRSV eukaryotic expression vector (In- 
vitrogen, Leek, The Netherlands). The constructs and control empty pR- 
cRSV vectors were linearized with ScaI before transfection. MDCK cells 
were washed three times with PBS, and 3 × 106 cells were electroporated 
(capacity: 960 p.F, voltage: 260 V) with 30 wg of plasmid DNA. Cells were 
cultured in normal culture medium supplemented with penicillin (100 U/ 
ml; GIBCO BRL) and streptomycin (100  i~g/ml; GIBCO BRL) for 24 h 
before selection in medium supplemented with G418 (0.480 mg/ml; Boeh- 
ringer). The G418-resistant cell populations were tested for glypican ex- 
pression in dotblot and Western blot assays and by immunocytochemistry 
using the mAbs $1 and 1Gll. 
Construction of the Glypican Mutants 
Sequences coding for the three potential HS attachment sites near the car- 
boxyl terminus of glypican were mutated. The bases 1,677 to 1,695 of the 
64K3 cDNA, cloned in Bluescript, were changed from AGC GGC TCG 
GGC AGC GGT to AGC GGC TCG GGC ACC GGT, to AGC GGC 
ACG GGC ACC GGT, or to ACC GGC ACG GGC ACC GGT, using 
the  Transformer  site-directed mutagenesis  kit  (Clonetech,  Palo  Alto, 
CA). These mutations, which replace the triple SG repeat in the protein 
by the sequences SGSGTG, SGTGTG or TGTGTG, were confirmed by 
restriction analysis and DNA-sequencing. The mutated 64K3cDNAs were 
ligated into the pRcRSV vector and used for the transfection of MDCK 
ceils as described above. 
A  syndecan-4/glypican  chimera  (35KN/64KC)  was  constructed  by 
PCR, starting from parts of the cDNAs for these proteins, subcloned in 
pBluescript, and using the primers T7 and TGC CAG GAG CTC CGT 
TCT  CT  (syndecan-4) and the primers T3  and  CCC AGA GCT CTC 
AGA GCA  GG  5  (glypican). The PCR products were verified by se- 
quencing, and ligated in pRcRSV using the enzymes HindllI, SacI, and 
XbaI. The resulting chimeric cDNA insert includes residues 1-458 of the 
35K17 sequence (David et al., 1992), the GAGCTC sequence (SacI), and 
residues 1785-2443  of the 64K3 sequence (David et al., 1990). Translation 
of this construct is predicted to initiate at the start ATG codon, preceded 
by the Kozak sequence, of the syndecan-4 cDNA and to be terminated by 
the TAA stop codon of the glypican cDNA, to yield a chimera composed 
of residues 1-145 (the signal peptide and ectodomain) of the predicted se- 
quence for human syndecan 4 and of residues 521-558 (C-terminus) of the 
predicted sequence for human glypican. All potential heparan sulfate gly- 
canation sites in this construct are derived from syndecan-4. 
Results 
Integral Membrane Proteoglycans 
Expressed by CaCo-2 Cells 
Confluent monolayers of CaCo-2 cells express several dif- 
ferent forms of cell surface heparan sulfate proteoglycan. 
This is  illustrated by Western blot analyses of the lipo- 
some-intercalatable proteoglycan fraction from these cells, 
using various syndecan, glypican and h-HS-specific mono- 
clonal antibodies (Fig. 1). Staining of the heparitinase-treated 
fractions with mAb 3G10, an antibody that recognizes the 
desaturated uronates on the HS "stubs" that remain asso- 
ciated with the core proteins after a heparitinase digestion, 
revealed multiple prominent bands with apparent molecu- 
Figure  1.  Identification  of  the  cell  surface  HSPGs  in  CaCo-2 
cells.  Hydrophobic  proteoglycans,  isolated  from  Caco-2  cells 
were treated (+) or not treated (-)  with heparitinase (Hase) and/ 
or chondroitinase ABC  (Case). Samples were analyzed by elec- 
trophoresis  in  SDS-polyacrylamide  gradient  gels,  followed  by 
electrotransfer to a  Zeta-probe membrane  and immunostaining 
with mAbs raised against  the cell surface-associated proteogly- 
cans from human lung fibroblasts: (a)  mAb  3G10,  an anti-AHS 
antibody that reacts with any HSPG core after treatment with he- 
paritinase; (b) mAb S1 for glypican; (c) mAb 2E9 for syndecan-1 
and -3; (d) mAb  6G12  for syndecan-2; (e) mAb  8G3  for synde- 
can-4. 
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35-kD bands were identified as, respectively, syndecan-1, 
glypican,  syndecan-2  (fibroglycan)  and  syndecan-4  (am- 
phiglycan/ryudocan) by various core protein-specific anti- 
bodies. During culture, CaCo-2 cells also release HSPGs 
into the culture media (not shown). The single major ~60- 
kD core protein stained by mAb 3G10 in Western blots of 
heparitinase  digests  of these  fractions  was  identified  as 
glypican, suggesting that, as in many other cell types, this 
proteoglycan is shed from the surface of CaCo-2 cells. 
Polarity of the Expression of the Membrane-associated 
HSPGs in CaCo-2 Cells 
The distribution of the major membrane-associated hepa- 
ran sulfate proteoglycans over the apical and the basolat- 
eral cell surface domains of these epithelial cells was inves- 
tigated by growing the cells on semi-permeable filters in a 
Transwell Costar culture system, and submitting the cells 
to domain-specific biotinylation. The biotinylated cell sur- 
face proteoglycans were analyzed as described in Materi- 
als and Methods, and the results of these experiments are 
illustrated in Fig. 2 and summarized in Table I. 
Fig. 2 shows the Western blots of proteoglycan fractions 
isolated from apically or basolaterally biotinylated  cells, 
developed by chemoluminescent staining using avidin-linked 
alkaline phosphatase. Basolateral biotinylation yielded mul- 
tiple  strongly  labeled  core  proteins,  apical  biotinylation 
mostly a core protein of ~64 kD, suggesting that glypican 
was the main proteoglycan expressed at the apical mem- 
brane surface. For three major cell surface proteoglycans 
that were immunopurified from CaCo-2 cells, Table I lists 
the fraction of the total radiolabel that was retained on im- 
mobilized  streptavidin  when  this  proteoglycan  was  iso- 
lated  from metabolically labeled  cells that  were biotiny- 
lated  from  either  the  apical  surface,  the  basolateral 
Figure 2.  Characterization of the core proteins of the domain- 
specific  biotinylated  proteoglycans  expressed  in  CaCo 2  cells. 
Cells cultured in Transwell Costar culture plates and labeled with 
35SO42- for 22 h, were biotinylated  from either the apical (A) or 
basolateral (B) compartment; controls (C) were not biotinylated. 
Ceils were lysed with TX-100 buffer and the proteoglycans  were 
purified from these extracts by ion-exchange chromatography on 
Mono Q. The 35S-c0ntaining fractions were pooled, concentrated 
and treated with  heparitinase (Hase) and chondroitinase  ABC 
(Case). Treated (+) and nontreated (-) samples were analyzed 
by electrophoresis  in  a  gradient  SDS-polyacrylamide gel,  fol- 
lowed by transfer to a Zeta-probe membrane. The biotinylated 
proteoglycans  were detected by staining with an avidin-linked al- 
kaline phosphatase and by chemiluminescence. 
Table L Polarity of the Expression of the HSPGs 
in CaCo 2 Cells 
Cell Surface HSPG Expression in CaCo-2 Cells 
Biotinylated Fraction (Percent of total proteoglycan) 
Form  Detergent  A  B  C  A-C/B-C  n 
Glypican  TX  13  50  1  0.241  3 
OG  17  59  1  0.275  6 
Syndecan-  1  TX  1  16  0  0.062  2 
OG  2  23  1  0.045  1 
Syndecan-4  TX  2  18  1  0.058  1 
OG  3  23  1  0.090  l 
Cells were cultured in Transwell Costar  culture plates and labeled with 35SO2- for 22 h. 
Each separate experiment involved three cultures, analyzed in parallel. Test cells were 
biotinylated from either the apical (A) or basolateral (B) compartment. Controls were 
not biotinylated (C).  Cells were lysed with TX-100 buffer (TX) or OG buffer (OG), 
and the proteoglycans were immunopurified from these extracts. Biotinylated and 
non-biotinylated proteoglycans were separated on immobilized streptavidin and ana- 
lyzed for their 35S-content. The radioactivity associated with the biotinylated fraction 
(streptavidin-bound label) was expressed as a percentage of the total label recovered 
for that particular proteoglycan from the antibody column. Lack of 100% recovery 
was also observed when the biotinylations were performed in the presence of deter- 
gent, and reflects the relative inefficiency of the biotinylation procedure rather than 
the presence of substantial intracellular  pools (not shown). The number of separate ex- 
periments from where these numbers (or averages) were obtained is indicated (n). 
surface,  or not  biotinylated.  The results  of several inde- 
pendent  experiments  indicate  that  biotinylated  forms of 
35SO3Z--labeled syndecan-1 and -4 were virtually restricted 
to the basolateral membrane compartment of the CaCo-2 
cells. The 35SO32--labeled glypican, in contrast, was readily 
detectable in the apical compartment, but also in the baso- 
lateral  compartment.  Actually,  three  to four times more 
glypican was biotinylated in the basolateral than in the api- 
cal labeling procedure (A/B =  0.274; SEM =  0.053; n  =  6). 
To investigate the polarity of the shedding, glypican was 
also immunopurified from the apical and basolateral cul- 
ture media after 24 hours of labeling with 35SO42-. The ra- 
tio of apically shed glypican to basolaterally shed glypican 
was found to be ~0.38  (SEM  =  0.046;  n  =  4)  (Table II), 
indicating that glypican was shed to both culture compart- 
ments, but in relative amounts that were slightly different 
from the distribution of this proteoglycan over the corre- 
sponding membrane domains, with more glypican released 
to the apical medium than expected from the membrane 
distribution.  All  together, ~70%  of the  total  amount of 
35SO32--glypican synthesized during the 24 h  labeling pe- 
riod had ended up in the basolateral compartment of the 
culture system (basolateral membrane  +  basolateral cul- 
ture medium). 
The  polarity  of  the  expression  of the  syndecans  and 
glypican in  CaCo-2 cells  was  not  influenced  by the  col- 
lagen coats used in the above experiments, as experiments 
with cells cultured on noncoated filters yielded similar re- 
sults. Similar results were also obtained whether the cells 
were lysed in the filter chamber or lysed after excision of 
the filter, excluding the possible contribution of cells grow- 
ing on the vessel walls (Zurzolo, 1993).  Finally, the polar- 
ity of the heparan sulfate proteoglycan expression was also 
found to be similar in cells cultured for 8 or for 14 d  (re- 
suits not shown). 
Unconventional Sorting of Glypican 
Since  most,  if not  all,  GPI-linked  proteins  in  epithelial 
cells are  restricted  to the  apical surface  (Le Bivic et al., 
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Glypican-transfected MDCK Cells 
Polarity of the Shedding of Glypican 
Ratios of the apical and basal shed glypican 
Source  Type  Label  A/B  n  o 
CaCo-2  endogenous  sulfate  0.380  4 
methionine  0.564  2  B. 
O 
glucosamine  0.237  2 
MDCK  wild  sulfate  1.010  3 
methionine  0.935  2 
two-chain  sulfate  2.160  3 
one-chain  sulfate  2.980  4 
no-chain  methionine  9.046  3 
chimera  sulfate  0.576  3 
Glypican was immunopurified from the apical and basolateral culture media of cells 
that were cultured on Transwell Costar plates and labeled with 35SO42-, 3H-glu- 
cosamine, or [35S]methionine  and cysteine. For the experiments with CaCo-2 cells 
glypican was pre-purified from the media by absorption on DEAE. For the experi- 
ments with MDCK cells glypican was immunopurified directly from the media. Simi- 
lar progressive increases in A/B ratios with decreasing chain numbers were also ob- 
served when glypican from proteoglycan-transfectant  MDCK cells was pre-purified 
on DEAE (not shown). The chainless form of glypican, however, failed to bind to 
DEAE. The numbers represent averages of the ratios of the amounts of label recov- 
ered from the apical and basolateral media. The number of independent experiments 
from where these averages were derived is indicated (n). 
1989; Mostov et al., 1992), the mainly basolateral distribu- 
tion of glypican was unexpected. To confirm that the baso- 
lateral glypican was GPI linked, glypican isolated from ba- 
solaterally biotinylated cells was incorporated into liposomes 
and  tested  for susceptibility  to  phosphatidylinositol-spe- 
cific phospholipase  C  (Fig.  3).  After recentrifugation  of 
the liposomes on sucrose gradients, biotinylated glypican 
was  recovered  from  the  bottom  fractions  when  treated 
with PLC, but from the top fractions when left untreated. 
Biotinylated syndecan-1, isolated from the same cells, was 
recovered from the top fractions and not affected by the 
PLC treatment. 
On  the  other  hand,  GPI-linked proteins  are  not  effi- 
ciently solubilized by certain detergents, including cold so- 
lutions of TX-100, possibly because their lipid anchors as- 
sociate with membrane domains of unique lipid compositions 
(Hooper and Turner, 1988; Brown and Rose, 1992).  CaCo- 
2 cells cultured on Transwells were therefore biotinylated 
and successively extracted with cold TX-100 and octylglu- 
coside. Dot blot analyses and quantitative immunopurifi- 
cations  of the  HSPGs from these  extracts revealed that 
glypican was significantly, but only partially, solubilized in 
cold TX-100 (~33%), while syndecan-1, which is a trans- 
membrane proteoglycan, was quantitatively extracted by 
TX-100 (>95%).  Analysis of the biotinylated fractions in 
the different extracts showed that neither the glypican ex- 
tracted with TX-100 (Table I) nor the residual glypican ex- 
tracted  with  octylglucoside  (A/B  =  0.171)  were apically 
polarized. Yet, similar biotinylation and successive extrac- 
tion experiments with cold TX-100 and octylglucoside in- 
dicated that, as predicted for glypiated proteins, recovery 
of biotinylated human  carcinoembryonic antigen  (CEA) 
was virtually limited to apical labeling reactions and to the 
octylglucoside extracts of these CaCo-2 cells (Fig. 4). 
Biotin-accessible 35SO32--glypican could also be recov- 
ered from both the basolateral and apical surfaces of the 
CaCo-2 cells after brief labeling periods (0.5-4 h), whereby 
the accumulation of this proteoglycan on the basolateral 
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Figure 3.  Sensitivity to phospholipase C of the basolaterally ex- 
pressed glypican and syndecan 1. CaCo-2 cells cultured on Trans- 
well Costar culture plates and labeled with 3sSO42- for 22 h, were 
biotinylated from the basolateral compartment. Glypican (A and 
B) and syndecan-1 (C and D) were immunopurified from the cell 
extracts on antibody columns  and incorporated into liposomes. 
Incorporated materials were separated from the nonincorporated 
materials by centrifugation  on a sucrose  gradient,  before treat- 
ment with phospholipase C (PLC). All label comigrated with the 
liposomes  (not  shown).  The  liposome-incorporated  fractions 
were treated (+PLC) or nontreated (-PLC) with PLC, treated 
(A and C) and nontreated samples (B and D) were recentrifu- 
gated on a sucrose gradient, and each fraction of the gradient was 
analyzed for its streptavidin-binding  35S-content. 
cell surface exceeded that on the apical surface from the 
initial measurements on (Fig. 5 A). Pulse--chase experiments, 
whereby metabolically labeled cultures were biotinylated 
after various time periods of culture in precursor-free me- 
dium, indicated that apical and basolateral biotin-accessi- 
ble 35SO32--glypican forms were cleared from the cell sur- 
face at similar rates (Fig. 5 B). Virtually all (90%), of the 
metabolically labeled  glypican that was cleared  from the 
cells during the chase period was recovered in the culture 
media. Most of this shed glypican was accumulating in the 
basolateral medium (ratio of apical over basolateral shed 
35SO32--glypican  =  0.472).  Other pulse-chase experiments, 
in which the cells were vectorially biotinylated at the end 
of the metabolic labeling pulse and then chased, indicated 
that the apically or basolaterally biotinylated glypican was 
mostly released to the ipsilateral medium compartment (in 
both cases ~75% of the total shed biotinylated proteogly- 
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CEA in CaCo-2 cells.  Caco-2 cells  grown on Transwell  Costar 
culture plates were biotinylated from either the apical (A) or ba- 
solateral  (B) compartment; controls (C) were not biotinylated. 
Cells were extracted successively with cold TX-100 (TX-100) and 
octylglucoside (OG). All  biotinylated  components  present  in 
both the TX-100 and OG extracts were concentrated on immobi- 
lized  streptavidin.  After several washes,  the streptavidin  beads 
were boiled for 10 min in 2% SDS-sample buffer and analyzed 
by electrophoresis  on a  4%  Nusieve agarose gel.  The samples 
were transferred to a Zeta-probe membrane and immunostained 
with an anti-CEA mAb. 
can). Shedding to the contralateral  compartment  (~25% 
of the total  shed biotinylated proteoglycan) in these ex- 
periments  could be  attributed  to  a  transcytotic pathway, 
since in control experiments no diffusion to the contralateral 
medium  compartment  could  be  measured  when  labeled 
glypican was added to the apical or basal culture medium 
and  label  accumulating in  the  contralateral  medium  was 
measured for up to 24 h. Moreover, from this data we cal- 
culated that the relative sizes of the apical and basolateral 
biotinylated  membrane-associated  pools  (A/B  =  ~0.25) 
and the combined magnitudes  of the ipsilateral  and con- 
tralateral  sheddings could account for higher apical/basal 
glypican  ratios  in  media  compartments  than  in cell com- 
partments [predicted ratio for the media =  (0.25  x  0.75)  + 
(1 x  0.25)/(1  x  0.75)  +  (0.25  x  0.25)  =  0.538]. These data 
suggested that sorting rather than differential stabilization 
or  turnover  mechanisms  were  at  the  basis  of this  unex- 
pected bipolar expression of glypican. 
Finally, transfection experiments, in which a cDNA cod- 
ing  for  human  glypican  was  introduced  into  polarized 
MDCK cells, indicated  that the basolateral  expression of 
glypican was not a particularity of the CaCo-2 cell system. 
Western  blotting  demonstrated  that  the  glypican  ex- 
pressed by the transfectant clones had a core protein of 64 
kD, that it was sensitive  to heparitinase  only, and that it 
was shed into the culture medium (Fig. 6). A  domain-selec- 
tive  biotinylation  of two  different  MDCK  clones  showed 
that  also in this cell system the 35SO32--glypican was dis- 
tributed over both the apical and basolateral surfaces (Ta- 
ble III). Quantification of the amounts of 35SO32--glypican 
accumulated into the culture media of these cells revealed 
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Figure 5.  Kinetics  of the labeling and chase of label from the bi- 
otinylated  apical  and  basolateral  glypican fractions in  CaCo-2 
cells. CaCo-2 cells were grown on Costar Transwell culture plates 
and biotinylated from either the apical or the basolateral com- 
partment after varying times of 35SO4 incorporation (A), or after 
varying times of chase of the label from cells labeled for 24 h (B). 
Control cells  were not biotinylated.  The biotinylated  fractions 
were isolated and analyzed as described in Table I. 
that, as in CaCo-2 cells, this proteoglycan was shed to both 
the apical and the basolateral culture media (Table II). 
These  experiments  confirmed  that  in  polarized  cells 
glypican did not behave like most other GPI-linked pro- 
teins. 
The HS Chains Interfere with the Apical 
Sorting of Glypican 
Current  models  for  the  apical  sorting  of  GPI-anchored 
proteins  (Simons  and Wandinger-Ness,  1990; Brown and 
Rose,  1992;  Hooper,  !992)  propose  that  GPI-anchored 
proteins and glycolipids associate in clusters during trans- 
port through the Golgi, whereby the GPI-linked molecules 
would become insoluble in TX-100 at the time the clusters 
are formed. These clusters would then segregate, associate 
with the elements  of a  specialized sorting machinery and 
be  directed  to  the  apical  surface  of polarized  epithelial 
cells. Glypican does not fit in this model, escaping in part 
from clustering into these domains (partial Triton solubil- 
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and  mutant  glypicans  expressed  in 
transfectant  MDCK cells. MDCK cells 
transfected with the wild type (3S), the 
SGSGTG (2S) or the SGTGTG (IS) 
mutant  form of the  64K3 cDNA  for 
human  glypican  (A),  or  the  chimera 
(B) were cultured on plastic substrates 
and  solubilized with  OG buffer.  Pro- 
teoglycan isolated  from the detergent 
extract (by absorption  on DEAE) was 
not  treated  (-)  or  treated  (+)  with 
heparitinase  (Hase),  fractionated  by 
SDS-agarose  (glypican), or polyacryl- 
amide  (chimera)  gel  electrophoresis, 
and transferred to a Zeta-probe mem- 
brane. The transfectant proteins were visualized by immunostaining using the mAbs $1 and 1Gll for glypican (A) or 8G3 (syndecan-4) 
for the chimera (B). Nontransfectant  MDCK cells do not express the $1, 1Gll, and 8G3 epitopes (not shown). 
ity of the cell surface--exposed forms) and failing to segre- 
gate  (apical and basolateral expressions). Glypican may, 
for example, associate with a heparin-binding protein that 
contains basolateral determinants and mediates its trans- 
fer to the basolateral membrane. Alternatively, HS chains 
with attachment sites located near the carboxyl terminus 
of the core protein, close to the membrane, might prevent 
the interaction of glypican with the sorting components. 
To test these hypotheses, cells were treated with chlorate, 
to inhibit glycosaminoglycan sulfation, and glypican mu- 
tants of differing HS acceptor site valencies were constructed 
and expressed in MDCK cells. 
Chlorate treatment of the CaCo-2 cells reduced the sul- 
fation of the HSPGs t o 6% of the normal level (not shown), 
but did not affect the polarized expression of glypican (nor 
that of syndecan-1) in these cells. In chlorate-treated cells, 
3H-glucosamine-labeled glypican was found at the baso- 
lateral surfaces (Table IV) and was shed in both the apical 
and basolateral compartments (not shown), in similar pro- 
portions as in control cells, suggesting that normally sul- 
fated chains were not required for interacting with a hypo- 
Table IlL Polarity of the Cell Surface Expression of Wild Type 
and Mutant Glypican in MDCK Transfectants 
Cell Surface Expression of Glypican in Transfectant  MDCK Cells 
Ratios of the apical and basolateral biotinylated fractions 
Form  Label  A-C/B=C  n  HSa +  HSb =  HSt 
Wild type  sulfate  0.565  (5)  108 +  192 =  300 
Two-chain  sulfate  0.970  (7)  98 +  102 =  200 
One-chain  sulfate  1.180  (4)  54 +  46 =  100 
No chain  methionine  1.650  (2) 
Chimera  sulfate  0.543  (3) 
Cells were cultured in Transwell Costar culture plates and labeled with 35S042-  or 
with [3SS]methionine  and cysteine for 22 h. Test cultures were biotinylated from ei- 
ther the apical or basolateral compartment. Control cultures were not biotinylated. 
The cells were lysed with OG buffer, and glypican  was direcdy immunopurified from 
these extracts. The apical (A) and basolateral (B) biotinylated fractions were isolated 
by incubation with immobilized streptavidin and analyzed for their 35S-content.  The 
amount of label retained on streptavidin in isolates from control cultures (C) was sub- 
stracted from these numbers. The number of separate experiments from where these 
average ratios were obtained has been indicated (n).  In the last column fictive num- 
ber's for the apical (HS,), basolateral (HSb) and total (HSt) HS values are given that 
correspond to the A/B ratios that were experimentally obtained for the corresponding 
proteoglyean  forms, and to a model whereby the cells express constant amounts (i.e., 
100 copies) of glypican  coreprotein substituted with either three, two or one structur- 
ally similar HS chains. 
thetical  basolateral  sorting  machinery.  The  ratios  that 
were obtained, however, were slightly different from those 
obtained in 35S-sulfate-labeling experiments. Cellular 3H- 
glypican was even more preponderant over the basolateral 
surface (A/B ,,~ 0.170) than the 3S-glypican (A/B =  0.274). 
This suggests some differences in the sulfation of glypican 
between different culture compartments, but without rela- 
tionship to sorting. 
To test whether the HS chains might prevent the polar- 
ized expression of glypican, the three serines at the poten- 
tial HS attachment sites near the carboxyl terminus were 
converted into threonines, to create two-chain, one-chain, 
and  unsubstituted  forms  of  glypican.  Autoradiographic 
analyses (not shown)  and Western blot analyses of wild 
type and mutant glypican forms, immunoprecipitated from 
transfectant MDCK cells, indicated a progressive increase 
in  average relative molecular weight consistent with the 
predicted increase in chain valency (Fig. 6). The one-, two-, 
and  three-chain  forms  of glypican had  core  proteins  of 
identical  sizes,  and  heparan  sulfate  was  the  only  gly- 
cosaminoglycan identifiable  in  these  proteoglycans.  The 
sizes of the free heparan sulfate chains, prepared by alkali- 
borohydride of the  proteoglycans,  were  similar  for  the 
three forms, whereas the sizes of the chain clusters, pre- 
pared by trypsin digestion, increased with the predicted in- 
Table IV. Effect of Chlorate on the Polarity of the Expression 
of Glypican and Syndecan-1 in CaCo-2 Cells 
Effect of Chlorate on the Cell Surface Expression 
of the HSPG in CaCo-2 Cells 
Biotinylated Fraction (Percent of total proteoglycan) 
Forms  Treatment  A  B  C  A-C/B-C 
Glypican  none  3.3  20.2  0.5  0. ! 63 
chlorate  3.0  17.3  0.4  0.173 
Syndecan-  1  none  1.2  15.9  0.1  0.069 
chlorate  2.1  11.0  0.3  0.190 
Cells were cultured in Transwell Costar culture plates, treated or not treated with 
chlorate, and labeled with 3H-glucosamine  for 22 h. Test cells were biotinylated from 
either the apical (A) or basolateral (B) compartment. Controls were not biotinylated 
(C). The ceils were lysed with octylglucoside buffer and the proteoglycans were im- 
munopurified from these  extracts.  Biotinylated and nonbiotinylated proteoglycans 
were separated on immobilized streptavidin and analyzed for their 3H-content. The ra- 
dioactivity associated with the biotinylated fraction (streptavidin-bound label) is ex- 
pressed as a percentage of the total label recovered for that particular proteoglycan 
from the antibody column. 
Mertens et al. SubceUular Expression of GPI-anchored Proteoglycan  493 crease  in  maximal  chain  number  in  these  clusters  (not 
shown). The TGTGTG mutant had an apparent molecular 
weight of ~64 kD  (Fig. 7),  and was not substituted with 
glycosaminoglycan as  revealed  by its  resistance  to  hep- 
aritinase  and  chondroitinase  ABC  (not  shown).  These 
glypican mutants were then tested for the polarity of their 
expression in 35S-sulfate  and in [35S]cysteine  plus [35S]me- 
thionine-labeled  cells.  The  chainless  mutant  was  mostly 
detected at the apical surface of the transfectant cells (Fig. 
7  and  Table  III), and  the  shedding  of this  mutant  was 
nearly limited to the apical compartment (Fig. 7 and Table 
II). Taken together, the majority (~90%) of the chainless 
glypican mutant was sorted to the apical (membrane and 
culture  medium)  compartment.  The  one-  and  two-chain 
mutant  proteoglycan  forms of glypican,  in  contrast,  had 
distributions  that  were intermediate  between that of the 
wild type proteoglycan and that of the chain-less form (Ta- 
bles II and III). The results of these experiments suggest 
that the presence of the HS chains interferes with the api- 
cal sorting signal provided by the GPI anchor and prevents 
the polarized expression of glypican in MDCK cells. 
As a  further test of this interpretation, we constructed 
an artificial glypiated HSPG in the form of a  syndecan-4/ 
glypican  chimera.  This  construct  was  composed  of  the 
complete ectodomain of this syndecan, providing the sites 
for substitution with HS, and the 38 last residues of glypi- 
can, providing the determinants that are required for the 
GPI anchor attachment (the site for the transamidation re- 
action  and  the  hydrophobic  signal  peptide-like  COOH- 
terminal sequence).  Syndecan-4 was chosen to make this 
construct because the sites for substitution with HS in this 
syndecan are more proximal to the cell surface than in the 
other forms, possibly providing for  a  better imitation of 
the  display  of the  chains  in  glypican.  After  transfection 
Figure  7.  Polarity of the expression of the chainless-glypican  mu- 
tant in transfectant MDCK cells. The MDCK clone  expressing 
the TGTGTG-glypican mutant was grown on Transwell  Costar 
culture plates and labeled with [35S]cysteine and [35S]methionine 
for 22 h. Apical (A) and basolateral (B) culture media were col- 
lected separately. The cells were biotinylated from either the api- 
cal (A) or basolateral (B) compartment; controls (C) were not bi- 
otinylated.  Cells  were  lysed  with  OG  buffer.  Glypican  was 
immunopurified  directly from the culture media and cell extracts. 
The biotinylated  immunopurified cellular  glypican was isolated 
on immobilized  streptavidin.  Total  apical  and basolateral me- 
dium glypican, and apically and basolaterally  biotinylated cellular 
glypican  were  analyzed  by  SDS-PAGE  and  autoradiography 
without any prior heparitinase digestion. 
into MDCK cells, three independent cell clones expressed 
the chimera in a  bipolar fashion, both on the cell surface 
and  in  the  culture  media  (Tables  II and  III), consistent 
with the proposal that bipolar expression of glypiated pro- 
teoglycans is primarily due to the presence of the heparan 
sulfate chains. 
Discussion 
This study investigated the expression of HSPGs in polar- 
ized epithelial cells and revealed that glypican, unlike most 
other GPI-anchored proteins characterized to date,  does 
not have an exclusive or even preferential apical localiza- 
tion.  Glypican is  expressed  apically,  and  is  in  this  sense 
unique  amongst  the  cell  surface  proteoglycans  (investi- 
gated here),  but  to  a  large  extent  it is  also  coexpressed 
with the transmembrane HSPGs (syndecan-1 and -4), which 
appear  restricted  to  the  basolateral  surface  domains  of 
these  cells.  Gtypican is  also  shed  from these  membrane 
compartments into both the apical and basolateral culture 
media. Yet, a glypican mutant that forms a poor substrate 
for the glycanation machinery accumulates nearly quanti- 
tatively  in  the  apical  culture  compartments,  suggesting 
that the HS chains interfere with the polarized expression 
of this protein. The physiological significance of the latter 
observation remains uncertain, but leads us to the formu- 
lation  of two alternative hypotheses for further explora- 
tion. One is that substitution of GPI-linked core proteins 
with HS may represent a  means of overriding the  apical 
sorting signal conveyed by GPI anchors,  and control the 
subcellular expression of these  proteins in  polarized sys- 
tems.  The  other  is  that  this  interference  represents  a 
means of stabilizing or controlling the amount of HS and 
possibly of HS-associated ligands expressed at the  apical 
surface of the cells. Modulation of the glycanation of glyp- 
ican  or of this interference could provide a  basis for the 
variability of the  subcellular  expression  of glypican  that 
can be observed in situ. 
Basolateral  Expression of the Syndecans 
Immunocytochemical experiments previously reported by 
Rapraeger et  al.  (1986)  had  shown that  syndecan-1, ini- 
tially present  on  the  entire  surface  of the  membrane of 
mouse mammary epithelial  cells,  ultimately becomes se- 
questered at the basolateral cell surface as the cells polar- 
ize in vitro. The present results of domain-specific biotiny- 
lation  experiments  on  CaCo-2  cells,  indicating  that  all 
transmembrane proteoglycans expressed by these cells are 
concentrated in  the basolateral membrane compartment, 
extend this  observation to  other  cell types and  to  other 
members of the syndecan family. Numerous experiments 
have shown that sequences in the cytoplasmic domains of 
proteins  (e.g.,  polymeric immunoglobulin  receptor,  low 
density lipoprotein receptor) function  as basolateral tar- 
geting signals (Hopkins, 1991), and studies on the expres- 
sion of cytoplasmic deletion mutants of syndecan-1 (Miet- 
tienen et al., 1994)  and syndecan-4 (our own unpublished 
observations) in MDCK cells suggest that this is also the 
case for the syndecans. Although no consensus sequence 
has been identified so far, at least in some cases these sig- 
nals include a crucial tyrosine residue (Mostov et al., 1992). 
The cytoplasmic domains of the syndecans have 60-70% 
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three tyrosine residues.  It is possible that some of these 
residues function as a  basolateral sorting signal, but this 
has not been shown directly. Since the syndecans can bind 
extracellular matrix components via their heparan sulfate 
chains and probably intracellular structures via their cyto- 
plasmic domains, their confinement to the basolateral sur- 
face makes them prime candidates for anchoring cells to 
the underlying matrix and associated growth factors, but 
less  or unsuitable  for mediating heparan  sulfate--depen- 
dent processes that involve apical reactants. 
Bipolar Expression of Glypican 
Similar investigations on the subcellular expressions of the 
members of the family of the glypiated HSPGs had not 
been  reported  so  far.  The  present  results  indicate  that 
glypican, which is expressed in many different cell types, 
accounts for most of the apical HS in CaCo-2 cells, and ap- 
pear consistent with reports on the in situ localization of 
this proteoglycan in axonal projections that are thought to 
represent the equivalent of the apical compartments of po- 
larized simple epithelia (Karthikeyan et al.,  1994). Glypi- 
can, and the other members of this family possibly as well, 
represents therefore a logical candidate for mediating pro- 
cesses that involve apically exposed HS-dependent reac- 
tants  (e.g., anticoagulation, lipoprotein lipase anchoring, 
recruitment of circulating cells). Usually, however, GPI- 
linked  proteins are  found exclusively on the  apical  sur- 
faces of polarized epithelial cells, including MDCK  and 
CaCo-2 cells (Lisanti and Rodriguez-Boulan, 1990; Lisanti 
et al., 1990). The unexpected aspect of the present results, 
therefore, is the evidence for a nonpolarized expression of 
the hydrophobic PLC-sensitive form of this proteoglycan 
in cells that express other endogenous GPI-linked proteins 
such as carcinoembryonic antigen (Garcia et al., 1991) ex- 
clusively at their apical surfaces. In the presence of con- 
firmed correct sorting of reference GPI-linked proteins in 
these CaCo-2 cells, this finding and a similar aberrant po- 
larization of this proteoglycan in transfectant MDCK cells 
(which in contrast to CaCo-2 cells use only direct apical 
sorting  pathways)  suggests  that  glypican does  not  obey 
"classical" sorting rules. Basolateral expressions of GPI- 
linked proteins have been reported before in a few other 
exceptional  cases.  At  steady  state,  a  small  proportion 
(10%) of alkaline phosphatase can be detected at the ba- 
solateral side of CaCo-2 cells (Le Bivic et al., 1990).  This 
fraction originates from a small pool of newly synthesized 
alkaline phosphatase  that is missorted to the basolateral 
surface and inefficiently transcytosed. The indirect sorting 
pathway (basolateral delivery followed by transcytosis to 
the apical surface) has also been described for the GPI- 
linked 5' nucleotidase in hepatocytes, cells that are gener- 
ally accepted to have no direct transport pathways (Schell 
et al., 1992). Although these two GPI-linked proteins were 
detected at the basolateral membranes, their steady state 
levels at this site were much lower than what we found for 
glypican, as more than half of this proteoglycan accumu- 
lates in the basolateral compartments. 
Glycanation Interferes with the GPl-sorting  Signal 
Glycolipid self-association into  microdomains or  "rafts" 
that are recognized by specific sorting proteins is thought 
to form the basis for the budding of an apical vesicle (Si- 
mons and van Meer, 1988; Simons and Wandinger-Ness, 
1990).  GPI proteins are  thought to associate with these 
rafts, whereas proteins with destinations for the basolat- 
eral membrane would be excluded from these structures. 
The finding that epithelial GPI-anchored proteins and gly- 
cosphingolipids are associated with complexes that are in- 
soluble in cold solutions of detergents as TX-100, but effi- 
ciently extracted in cold solutions of octylglucoside (Brown 
and Rose, 1992), supports this model and TX-100 insolu- 
bility is taken as a measure of association with these rafts. 
The nonpolarized expression of glypican in both CaCo-2 
and  MDCK cells, together with an  unusual  TX-100 ex- 
tractability as compared to other glypiated proteins (e.g., 
CEA), suggest that a glypican-specific characteristic inter- 
feres with the normal apical sorting mechanism for GPI- 
linked  proteins.  The  results  obtained  with  the  glypican 
mutants, whereby the chainless form is nearly exclusively 
directed to the apical compartment and the proteoglycan 
forms  remain  essentially  unpolarized,  suggest  that  this 
characteristic consists in  the  presence of the  HS chains. 
Proteoglycan forms of glypican may escape from cluster- 
ing into these domains, for example, because they associ- 
ate with a protein containing basolateral determinants that 
mediates  their transfer to the  basolateral membrane.  In 
that case a direct participation of the HS chains in this as- 
sociation appears unlikely. The binding interactions of this 
glycosaminoglycan largely depend on its anionic proper- 
ties or specific sequence composition and chlorate, which 
prevents HS sulfation, does not affect the polarity of the 
glypican expression. We cannot exclude, however, that re- 
moving the chains changes the configuration of the protein 
to an extent that protein-protein association might be pre- 
vented. The experiments with the syndecan-4/glypican chi- 
mera suggest, however, that most of the glypican protein is 
dispensable and that the presence of HS suffices to induce 
the randomization of GPI-anchored proteins. The findings 
seem more consistent with an exclusion model. Clustering 
of GPI anchors is  thought to lead  to very close protein 
packings, from which the proteoglycan form of the mole- 
cule may tend to be excluded. Studies on the sorting of 
GPI-linked proteins in  a  Fischer rat  thyroid (FRT)  cell 
line and a Con A r mutant of MDCK cells, in addition indi- 
cate  that  clustering  of the  GPI  anchor  and  glycosphin- 
golipids is not sufficient for apical targeting, and that the 
interaction of GPI-linked molecules with VIP21/caveolin 
and additional adaptor proteins appear required for their 
apical sorting (Zurzolo et al., 1994). The HS chains in glyp- 
ican  are located near the carboxyl terminus  of the  core 
protein, close to the membrane and might prevent the in- 
teraction of glypican with such sorting components. To a 
certain  extent  such  exclusion  effects  of  the  HS  chains 
would be reminiscent of the function of the HS chains in 
the glomerular basement membrane, where they provide 
repellant-fixed negative charges that determine the selec- 
tivity barrier of the filtration apparatus.  Finally, we can 
probably also exclude that glypican, at first, is sorted cor- 
rectly to the apical surface followed by a HS dependent 
but chlorate-insensitive transcytosis to the basolateral sur- 
face. The short term labeling and the pulse-chase data do 
not support such a model. 
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Irrespective of the mechanism, the results obtained with 
the HS glypican mutants in MDCK cells represent one of 
the few examples of carbohydrate structures that can in- 
fluence the polarity of the expression of a protein, and in 
this case of a glypiated protein. These findings imply that 
HS  chains,  which  are  important for many proteoglycan 
ligand  binding  interactions  and  functions,  may  also  be 
physiological determinants  of the  location of these pro- 
teins  in specific membrane  compartments.  Control over 
targeting  signals  would  represent  a  novel  function  for 
these complex and versatile carbohydrates. In this context 
it may be relevant to recall that the  GPI-linked HSPGs 
identified so far (glypican, cerebroglycan, the protein en- 
coded by the OCI-5 transcript, K-glypican) share a unique 
cysteine motif and  that  the  primary sequences  of these 
proteins  appear  to be highly conserved, suggesting  that 
these proteins may support essential functions by them- 
selves  (e.g.,  association  with  caveolar-signaling  compo- 
nents).  Modulation of the glycanation of these  proteins 
may  determine  where  these  protein  functions  are  ex- 
pressed. In the case of glypican, a preliminary immunohis- 
tochemical survey of several tissues has indicated that the 
subcellular  expression  of this  protein  is  quite  variable, 
from near exclusive basolateral expressions to bipolar or 
pronounced apical localizations (Litwack et al., 1994; and 
our own unpublished results). In addition, for cerebrogly- 
can, the neuronal glypican-related GPI-anchored HSPG, 
it has been noticed that the specific axonal localization of 
this  proteoglycan,  observed  in  vivo,  is  not  reproduced 
when the neuronal cells are brought into culture, where it 
also decorates dendritic projections (Kumbasar, A., E. D. 
Litwack, C. S. Stipp, J. K. Ivins, A. Yang, and A. D. Lander. 
1994. Mol. Biol. Cell. 55:303a).  It is not known whether 
variable substitution of the glypican core occurs in vivo 
and therefore represents a potential steering mechanism, 
but studies on the effect of TGF-13 on syndecan-1 (Raprae- 
ger, 1989) and the existence of "part-time" proteoglycans 
such as CD44 and betaglycan suggest that the number of 
substituted  attachment  sites  within  a  proteoglycan core 
protein may vary and that unsubstituted core proteins may 
be expressed.  It is  also clear that  the  length  of the HS 
chains on a particular proteoglycan can vary depending on 
the cellular source or differentiation of the cell, and a sur- 
vey of a large number of cell lines indicates that the glyca- 
nation  of glypican is  indeed  quite  variable  (results  not 
shown). Such variation may be due to synthetic differences 
or to processing by glycosidases (Yanagishita, 1992). From 
the present experiments we cannot make any predictions 
on the possible effects of variations in chain length rather 
than chain number on the sorting of glypican, since the av- 
erage chain length was similar in all transfectants. We also 
observed no internal differences in HS chain length be- 
tween  apical  and  basolateral  forms  of  glypican  in  the 
CaCo-2 cells (where the HS chains were shorter than in 
the  transfectants)  that  could reflect such  an  effect (not 
shown). 
On the other hand, the moderate but reproducible en- 
hanced apical expressions of the two- and one-chain forms 
of glypican suggest the possibility that inverse glycanation- 
sorting relationships and variations in the HS content of 
glypican may result in the essentially nonpolarized expres- 
sion of large proteoglycan forms and the apical polariza- 
tion of less  glycanated, more glycoprotein-like forms of 
the proteoglycan. Should this be the case under physiolog- 
ical conditions, one consequence might be that, in a cell 
which reduces its glycanation machinery, the apical com- 
partment is less rapidly depleted of HS than the basolat- 
eral compartment. Calculations based on the data in Table 
III would indeed predict that, all other possible variables 
remaining  constant  (e.g.,  core  protein  production  and 
chain length or structure), ceils that produce two-chain in- 
stead of three-chain forms would have their apical mem- 
brane-associated  HS  levels  nearly  unchanged  while  se- 
verely reducing the levels associated with their basolateral 
membranes (Table III). Such an adaptation may allow a 
cell to maintain  the  activity of HS-dependent processes 
that occur in luminal compartments (e.g., anticoagulation) 
while processes that occur basolaterally (e.g., receptor ac- 
tivation) may be compromised. One other consideration, 
finally, is that conditions may occur where the chain inter- 
ference is overruled. The proteoglycan form of glypican is 
"missorted" in the two cell types and under the conditions 
that were tested here, but there is no evidence that this a 
general or obligate phenomenon. Should there be ways to 
override the "exclusion" effect of the HS chains on the en- 
try  of  glypican  into  normal  GPI-sorting  pathways  (the 
binding of ligand?), then entry of glypican in this pathway 
may provide the means for cells to enhance the expression 
of HS and heparin-binding proteins in the apical compart- 
ment.  In  that  case,  it  would  seem  worthwhile  to  test 
whether glypican might  not  function as a  carrier in  the 
transcytosis  of  heparin-binding  proteins.  Our  data  on 
CaCo-2 cells show that at least a fraction of the glypican 
that is expressed at the cell surface cycles between mem- 
brane compartments, which would be a minimal require- 
ment for this possibility. 
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